Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SoftMedX HealthcareHKSE:00648 +4.42%54 PB Ratio is 1.96 as of Aug. 25, 2026, which is 68% below its 10-year median of 6.09. GuruFocus rates HKSE:00648 with a GF Score™ of 54/100 and a GF Value™ of HK$2.52 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 611 Healthcare Providers & Services companies, SoftMedX Healthcare ranks better than 52.05% on this metric.
SoftMedX Healthcare Ltd stock PB Ratio (=1.96) is close to 5-year low of 1.96.
The historical rank and industry rank for SoftMedX Healthcare's PB Ratio or its related term are showing as below:
HKSE:00648'
s PB Ratio Range Over the Past 10 Years
Min: 0.3 Med: 6.09 Max: 83.64
Current: 1.97
During the past 13 years, SoftMedX Healthcare's highest PB Ratio was 83.64. The lowest was 0.30. And the median was 6.09.
HKSE:00648's PB Ratio is ranked better than 52.05% of 611
companies
in the Healthcare Providers & Services industry
Industry Median: 1.99
vs HKSE:00648: 1.97
During the past 12 months, SoftMedX Healthcare's average Book Value Per Share Growth Rate was -15.40% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of SoftMedX Healthcare was 41.80% per year. The lowest was -266.70% per year. And the median was -15.20% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
SoftMedX Healthcare PB Ratio Related Terms
SoftMedX Healthcare PB Ratio Historical Data
* Premium members only.
The historical data trend for SoftMedX Healthcare's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, SoftMedX Healthcare's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SoftMedX Healthcare PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SoftMedX Healthcare's PB Ratio distribution charts can be found below:
* The bar in red indicates where SoftMedX Healthcare's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
SoftMedX Healthcare (HKSE:00648) has a PB Ratio of 1.96 as of Aug. 25, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on SoftMedX Healthcare and its competitors. This is 68% below median its historical median of 6.09. Over the past decade, SoftMedX Healthcare's PB Ratio has ranged from 0.30 to 83.64. According to the industry distribution chart, SoftMedX Healthcare ranks #293 out of 611 companies in the Healthcare Providers & Services industry, placing it in the top 48%.
Is SoftMedX Healthcare's PB Ratio too high?
SoftMedX Healthcare's current PB Ratio of 1.96 is 68% below median its 10-year median of 6.09. Over the past 10 years, this metric has ranged from a low of 0.30 to a high of 83.64. The Healthcare Providers & Services industry median PB Ratio is 1.99. SoftMedX Healthcare's value of 1.96 is 1.5% below this industry median. Based on the distribution chart, SoftMedX Healthcare ranks #293 out of 611 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, SoftMedX Healthcare has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SoftMedX Healthcare's PB Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, SoftMedX Healthcare ranks #293 out of 611 companies for PB Ratio. This puts SoftMedX Healthcare in the upper half of its industry. The industry median PB Ratio is 1.99. SoftMedX Healthcare's value of 1.96 is 1.5% below this benchmark. Historically, SoftMedX Healthcare's own PB Ratio has ranged from 0.30 to 83.64 over the past decade. While the company's 10-year median is 6.09 vs. the industry median of 1.99, SoftMedX Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.99, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SoftMedX Healthcare's current PB Ratio of 1.96 is 1.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on SoftMedX Healthcare and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SoftMedX Healthcare's current PB Ratio is 1.96, which is 68% below median its own 10-year median of 6.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SoftMedX Healthcare stock overvalued right now?
Based on GuruFocus' analysis, SoftMedX Healthcare (HKSE:00648) is currently considered Possible Value Trap. The stock's GF Value™ is HK$2.52, compared to a current price of HK$0.59 — trading 76.6% below its estimated fair value. The current PB Ratio is 1.96, which is 68% below median its 10-year median of 6.09 and 1.5% below the Healthcare Providers & Services industry median of 1.99. SoftMedX Healthcare's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For SoftMedX Healthcare (HKSE:00648), the current PB Ratio is 1.96 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SoftMedX Healthcare (HKSE:00648) Overvalued in 2026?
Based on GuruFocus' analysis, SoftMedX Healthcare stock appears to be undervalued.
The current stock price of HK$0.59 is trading 76.6% below its estimated GF Value™ of HK$2.52.
GuruFocus considers SoftMedX Healthcare to be Possible Value Trap.
Key valuation signals for HKSE:00648:
PB Ratio: 1.96 (68% below median its 10-year median of 6.09)
GF Value™: HK$2.52 vs. price of HK$0.59 (76.6% below fair value)
Industry Position: 1.5% below the Healthcare Providers & Services median (#293 of 611)
No single metric tells the full story. See the HKSE:00648 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SoftMedX Healthcare Ltd is principally engaged in the distribution of medical and healthcare equipment and products. The Group has one reportable operating segment: medical and well-being business, for the Distribution of medical and healthcare equipment and products.
54GF Score
Get the complete analysis for HKSE:00648
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00648 has been successfully added to your 
